PDS Biotechnology Corporation — Cash Flow (NASDAQ:PDSB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 13.15 M-12.49 M-25.71 M-33.64 M-35.03 M -32.28 M Cash from investing activities 0———-29 K — Cash from financing activities 29.83 M48.89 M34.29 M16.38 M20.19 M 8.73 M Free cash flow 13.15 M-12.49 M-25.71 M-33.64 M-35.06 M -32.28 M

News

PDS Biotech amends Phase 3 trial to add accelerated approval path

PDS Biotech reports 9.6-month progression-free survival in prostate cancer study

PDS Biotech secures patent for cancer immunotherapy PDS0101

PDS Biotech stock soars after FDA meeting provides accelerated approval path

PDS Biotech submits amended protocol for phase 3 cancer trial

PDS Biotech secures new patent for cancer immunotherapy in Japan

PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why

PDS Biotech secures FDA meeting to discuss accelerated approval pathway

PDS Biotechnology Corporation (PDSB) Q3 2025 Earnings Call Transcript

PDS Biotech raises $5.3 million in registered direct offering

PDS Biotechnology stock falls after $5.3 million registered direct offering

PDS Biotech reports positive data on cancer immunotherapy mechanisms